Physician
Obstetrics & Gynecology
Dr. Lisa N. Abaid, MD
|
|
Give Review
Doctor Lisa N. Abaid, MD is an expert in the field of Obstetrics & Gynecology. She attended University of Miami Miller School of Medicine. University of Miami Miller School of Medicine is ranked 45/0 in Research/PrimaryCare. She received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (FACS)" and "Fellow (FACOG)". Lisa Abaid is also published. She has 32 publications published. The lastest publication: "Consolidation hyperthermic intraperitoneal chemotherapy and maintenance chemotherapy following laparoscopic cytoreductive surgery in the treatment of ovarian carcinoma.' She accepts Medicare.
Publications
- Consolidation hyperthermic intraperitoneal chemotherapy and maintenance chemotherapy following laparoscopic cytoreductive surgery in the treatment of ovarian carcinoma.
- The feasibility of administering varying high-dose consolidation hyperthermic intraperitoneal chemotherapy with carboplatin in the treatment of ovarian carcinoma.
- The incidence of postprandial nausea and nutritional regression in gynecologic cancer patients following intestinal surgery: A retrospective cohort study.
- Systemic and local hormone therapy for endometrial hyperplasia and early adenocarcinoma.
- A phase II study of modified dose-dense paclitaxel and every 4-week carboplatin for the treatment of advanced-stage primary epithelial ovarian, fallopian tube, or peri...
- Clostridial abdominal gas gangrene masquerading as a bowel perforation in an advanced-stage ovarian cancer patient.
- Pegfilgrastim Safely Administered on the Same Day as Dose-dense Chemotherapy for Patients with Advanced-stage Ovarian Carcinoma.
- Prevention of venous thromboembolic events after gynecologic surgery.
- Acute and Delayed Complications from Surgery and Adjuvant Radiotherapy in the Treatment of High-Risk Endometrial Cancer.
- Metastatic lobular breast carcinoma infiltrating a uterine leiomyoma.
- A pilot study evaluating a novel regimen comprised of carboplatin, paclitaxel, and bevacizumab for advanced-stage ovarian carcinoma.
- Borderline ovarian tumors and extended patient follow-up: an individual institution's experience.
- Extraordinarily Prolonged Disease Recurrence in a Granulosa Cell Tumor Patient.
- A retrospective review of the GelPort system in single-port access pelvic surgery.
- Perivascular epithelioid cell neoplasms: a systematic review of prognostic factors.
- Delayed staple erosion into the bladder after removal of a benign ovarian mass.
- Endometrial Adenocarcinoma with Concomitant Left Atrial Myxoma.
- What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman?
- Serous fallopian tube carcinoma: a retrospective, multi-institutional case-control comparison to serous adenocarcinoma of the ovary.
- Reducing publication bias of prospective clinical trials through trial registration.
- Reducing publication bias through trial registration.
- Relationship between crown-rump length and early detection of cardiac activity.
- The prognostic significance of optimal debulking in the setting of a complete clinical response for advanced ovarian carcinoma patients receiving maintenance chemother...
- Chemotherapy and patient co-morbidity in ventral site hernia development.
- Microscopic evaluation of lymph-node-bearing tissue in early-stage cervical cancer: a dual-institution review.
- The utility of routine follow-up procedures in the surveillance of uterine cancer: a 20-year institutional review.
- Leiomyosarcoma with synchronous clear cell ovarian carcinoma.
- Bevacizumab, paclitaxel and carboplatin for advanced ovarian cancer: low risk of gastrointestinal and cardiovascular toxicity.
- Sequential chemotherapy and radiotherapy as sandwich therapy for the treatment of high risk endometrial cancer.
- The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review.
- Improved overall survival with 12 cycles of single-agent paclitaxel maintenance therapy following a complete response to induction chemotherapy in advanced ovarian car...
Doctors Specialties
- Obstetrics
- Gynecology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACS)
- Fellow (FACOG)
Education
-
University of North Carolina Hospitals -
University of Miami Miller School of Medicine
Hospital
-
Hoag Memorial Hospital Presbyterian -
Pomona Valley Hospital Medical Center -
St. Joseph Hospital
Drug Facts
| NPI NUMBER | 1295943132 | |
| NPPES Provider LastName | ABAID | |
| NPPES Provider FirstName | LISA | |
| NPPES Provider ZIPCode | 926633509 | |
| NPPES Provider State | CA | |
| Specialty Description | Gynecological/Oncology | |
| Total Claim Count | 263.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 12.0 | |
| Percent Opioid Claims | 4.56 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1295943132 |
| Last Name Of The Provider | ABAID |
| First Name Of The Provider | LISA |
| View All |
Similar Doctors
|
Dr. Lisa B. Hirsch, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Jeffrey N. Podlas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lisa M. Worsch, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Marina Maslovaric, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Deirdre A. Habermehl, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gail S. Hebel, MD |